Purchase Order 75F40119P10488
- Not listed
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Maxcyte, Inc., a small business prime contractor, on June 16, 2020 for a "Scalable Transfection System." The contract has a ceiling value of $82,100 and a completion date of September 30, 2020. Maxcyte has previously provided specialized laboratory equipment and technologies, such as cell processing systems, electroporation, and scalable transfection systems, to federal agencies including...
- The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a one-year, firm-fixed-price purchase order to Maxcyte, Inc. for the lease of one MaxCyte® GT Flow Transfection System, valued at $100,000.00. The equipment will be used to support biomedical research at the agency's facilities in Bethesda, Maryland. This award is not associated with a larger contract vehicle and does not utilize a set-aside designation. Maxcyte, Inc. is...
- The Department of Veterans Affairs Veterans Health Administration awarded a $165,000.00 firm fixed price purchase order to Maxcyte, Inc., a leading commercial cell engineering company, for the provision of specialized laboratory equipment and technologies. This contract, which did not utilize a set-aside designation, is for the delivery of transfection systems to support the agency's biomedical research and clinical care missions. Through past prime federal contract awards, Maxcyte has...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Maxcyte, Inc., a small business, for the procurement of a MaxCyte ATX Scalable Transfection System with software licenses. The contract has a potential value of $50,069.70 and was awarded on March 18, 2019 with a completion date of June 2, 2019. The award was made on a sole-source basis under the...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a commercial cell engineering company. The $24,200.00 contract is for the provision of MAXCYTE PROCESSING ASSEMBLIES. Maxcyte has previously held prime federal contracts with agencies like NIH, the Food and Drug Administration, and Department of Veterans Affairs to deliver specialized...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $59,500 purchase order to Maxcyte, Inc. to acquire a MaxCyte ATX Scalable Transfection System, along with processing assemblies and software licenses. The non-competitive award was justified as Maxcyte's proprietary electroporation technology is necessary to allow for the manipulation of transcription factor protein expression. The purchase...
- This is a $120,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Maxcyte, Inc., a commercial cell engineering company, to provide specialized laboratory equipment and technologies such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services to support NIDA's...
- This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maxcyte, Inc. for a Transfection System. The contract has a firm fixed price of $81,385.00 and was awarded on August 8, 2018 with a completion date of September 7, 2018. The award was made without a set-aside. Maxcyte, Inc. is a commercial cell engineering company that has previously provided specialized laboratory equipment...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Maxcyte, Inc. The contract is for the provision of an EXPERT STX SCALABLE TRANSFECTION SYSTEM, a specialized laboratory technology, to support the agency's biomedical research mission. The contract has a ceiling value of $107,300.00 and a period of performance through September 20, 2024. Maxcyte, Inc. is a...
- The Department of Health and Human Services' Food and Drug Administration awarded a firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for an INCUCYTE S3 LIVE-CELL ANALYSIS SYSTEM or equivalent. The $134,622.30 contract will be performed in Herndon, Virginia and supports the FDA's Division of Applied Regulatory Science in studying the chronic effects of drugs on cell cultures containing human organ features. Government Scientific Source Inc. is a leading...
The U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $114,087.00 firm fixed-price purchase order to Maxcyte, Inc., a small business company, for the provision of an electroporator and scalable transfection system. This contract supports the FDA's biomedical research and regulatory missions, as Maxcyte has provided similar specialized laboratory equipment and technologies, such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services, to other federal agencies like the National Institutes of Health (NIH) and Department of Veterans Affairs (VA) through past prime contract awards. The contract has a total small business set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Electroporator & Scalable Transfection System | FDA-1213082 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 6/21/19, 2:21 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $114.1k | 8/13/19 |